Related Experiment Video
Updated: Jun 18, 2026

Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
Published on: July 27, 2018
Biomonitoring state of the science: a report on a panel presentation and round table discussion
1Pacific Northwest Agricultural Safety and Health Center at the University of Washington, Seattle, Washington 98195-7234, USA. mkeifer@u.washington.edu
Abstract:
The paper summarizes an open panel discussion and breakout session by scientists and lay participants that focused on new approaches to identifying exposure to pesticides in humans during the New Paths: Health and Safety in Western Agriculture conference, November 11-13, 2008. Featured were reports on the available results from the Washington State Cholinesterase Monitoring Program, a statewide program for handlers of class I and II organophosphate (OP) and carbamate pesticides, identification of adducts to inhibited cholinesterase by use of protein digestion and mass spectrometry and antibody-based methods, including enzyme-linked immunosorbent assay (ELISA) for pyrethroids. One presenter proposed that the Environmental Protection Agency (EPA) should establish that pesticide registrants develop and provide diagnostic and/or biomonitoring tools to assess human exposure to their chemicals in the process of and as a requirement for pesticide registration. Finally, a follow-up breakout session focused on the new methods presented in the panel and discussion of the speaker's proposal for EPA. Breakout discussants pointed out the benefits of such a proposal but also pointed to some of its weaknesses. Several scientists suggested that a requirement that public release of analytical methods and identity of metabolites and methods for synthesizing metabolites would provide more flexibility to the academy in conducting studies of potential human exposure.
Related Concept Videos
Therapeutic Drug Monitoring: Overview and Classification
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Therapeutic Drug Monitoring: Affecting Factors
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
